Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

PLSE

Pulse Biosciences (PLSE)

Pulse Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PLSE
FechaHoraFuenteTítuloSímboloCompañía
09/05/202408:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
09/05/202407:00Business WirePulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode SystemNASDAQ:PLSEPulse Biosciences Inc
07/05/202415:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLSEPulse Biosciences Inc
07/05/202415:05Business WirePulse Biosciences Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
02/05/202407:00Business WirePulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000NASDAQ:PLSEPulse Biosciences Inc
24/04/202415:05Business WirePulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024NASDAQ:PLSEPulse Biosciences Inc
28/03/202415:12Business WirePulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
28/03/202415:10Business WirePulse Biosciences Announces Plans to Initiate a Rights OfferingNASDAQ:PLSEPulse Biosciences Inc
14/03/202415:05Business WirePulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024NASDAQ:PLSEPulse Biosciences Inc
08/03/202412:17Business WirePulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode SystemNASDAQ:PLSEPulse Biosciences Inc
14/02/202407:00Business WirePulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility StudyNASDAQ:PLSEPulse Biosciences Inc
31/01/202407:00Business WirePulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF SymposiumNASDAQ:PLSEPulse Biosciences Inc
02/01/202407:00Business WirePulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac ClampNASDAQ:PLSEPulse Biosciences Inc
20/12/202307:00Business WirePulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac CatheterNASDAQ:PLSEPulse Biosciences Inc
27/11/202316:29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PLSEPulse Biosciences Inc
21/11/202307:00Business WirePulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous ElectrodeNASDAQ:PLSEPulse Biosciences Inc
17/11/202308:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
15/11/202315:05Business WirePulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:PLSEPulse Biosciences Inc
13/11/202316:21Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PLSEPulse Biosciences Inc
13/11/202307:00Business WirePulse Biosciences Reports Business Updates and Third Quarter 2023 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
10/11/202315:56Business WireUPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference CallNASDAQ:PLSEPulse Biosciences Inc
30/10/202315:05Business WirePulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023NASDAQ:PLSEPulse Biosciences Inc
24/10/202307:00Business WirePulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac SurgeryNASDAQ:PLSEPulse Biosciences Inc
02/10/202307:00Business WirePulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation StudyNASDAQ:PLSEPulse Biosciences Inc
29/09/202307:00Business WirePulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP SummitNASDAQ:PLSEPulse Biosciences Inc
27/09/202307:00Business WirePulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual MeetingNASDAQ:PLSEPulse Biosciences Inc
07/09/202315:05Business WirePulse Biosciences to Present at Gilmartin Group Emerging Growth ShowcaseNASDAQ:PLSEPulse Biosciences Inc
30/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PLSEPulse Biosciences Inc
24/08/202315:05Business WirePulse Biosciences Clarifies Details of Recent S-3 FilingNASDAQ:PLSEPulse Biosciences Inc
11/08/202315:49Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PLSEPulse Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:PLSE

Su Consulta Reciente

Delayed Upgrade Clock